1[1]Vischetti M,Zito F,Maria Benedetta Donati,el al.Analysis of gene environment interaction in coronary heart disease:fibrinogen polymor-phisms as an example.Ital Heart J,2002,3:18223.
2[3]Kant JA,Fornace AJ,Saxe D,et al.Evolu-tion and organlza-tion of the fibrinogen lo-cus on chromosome 4:gene duplication accom-panied by transposition and inversion.Proc Natl Acad Sci USA,1985,82:2344-2348
4[5]Lowe GD,Rumley A,Mackie IJ.Plasma fibrinogen.Ann CI in Biochem,2004,41:430-440.
5[6]Behague I,Poifier O,Nicaud V,et al.fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patient with myocardial infarction the ECTIM study.Circulation,1996,93:440-449.
6[7]Danesh J,Lewington s,Thompson SG,et al.Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality:an individual participant meta -analysis.JAMA,2005,294:1799-1809.
7Fischman D, Leon M,Bain D, et al.A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary disease. N Engl J Med, 1994,331:496-501.
8Savage M P, Fischman D L, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent restenosis study[STRESS] investigators. J Am Coll Cardiol, 1998,31:307-311.
9Kastrati S, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol, 1997,30:1428-1436.
10Erbel R, Haude M, Hopp H W, et al. Restenosis stent(REST) study: Randomized trial comparing stenting and balloon angioplasty for treatment of restenosis after balloon angioplasty(abstract). J Am Coll Cardiol,1996,27(Suppl A):139-143.
